Minerva Historical Financial Ratios
| NERV Stock | USD 2.26 0.00 0.00% |
Minerva Neurosciences is lately reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Invested Capital of 0.0 will help investors to properly organize and evaluate Minerva Neurosciences financial condition quickly.
Minerva |
About Minerva Financial Ratios Analysis
Minerva NeurosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Minerva Neurosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Minerva financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Minerva Neurosciences history.
Minerva Neurosciences Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Minerva Neurosciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Minerva Neurosciences sales, a figure that is much harder to manipulate than other Minerva Neurosciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Roic
Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Revenue Per Share
The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.Most ratios from Minerva Neurosciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Minerva Neurosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.At this time, Minerva Neurosciences' Short Term Coverage Ratios is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to climb to 0.04 in 2024, despite the fact that Book Value Per Share is likely to grow to (4.16).
| 2023 | 2024 (projected) | Interest Debt Per Share | 13.88 | 14.57 | Revenue Per Share | 7.26 | 6.46 |
Minerva Neurosciences fundamentals Correlations
Click cells to compare fundamentals
Minerva Neurosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Minerva Neurosciences fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 9.99 | 1.81 | 4.29 | (0.42) | (1.41) | (1.34) | |
| Book Value Per Share | 5.7 | 10.32 | 1.49 | (3.75) | (4.37) | (4.16) | |
| Operating Cash Flow Per Share | (8.91) | (6.63) | (4.61) | (4.62) | (2.27) | (2.39) | |
| Pb Ratio | 9.99 | 1.81 | 4.29 | (0.42) | (1.41) | (1.34) | |
| Free Cash Flow Per Share | (8.91) | (6.63) | (4.61) | (4.62) | (2.27) | (2.39) | |
| Roic | (2.65) | 0.0368 | (5.49) | (0.57) | (0.43) | (0.45) | |
| Net Income Per Share | (14.8) | 0.38 | (9.35) | (7.3) | (4.61) | (4.84) | |
| Payables Turnover | 0.009706 | 0.0697 | 0.0549 | 0.008779 | 0.0172 | 0.0192 | |
| Cash Per Share | 9.4 | 4.97 | 11.38 | 6.76 | 6.3 | 8.58 | |
| Pocfratio | (6.39) | (2.82) | (1.39) | (0.34) | (2.71) | (2.84) | |
| Interest Coverage | (67.02) | (468.36) | (7.17) | (3.41) | (2.79) | (2.93) | |
| Pfcf Ratio | (6.39) | (2.82) | (1.39) | (0.34) | (2.71) | (2.84) | |
| Days Payables Outstanding | 37.6K | 5.2K | 6.6K | 41.6K | 21.3K | 30.4K | |
| Income Quality | 0.84 | 0.6 | (17.43) | 0.49 | 0.77 | 0.52 | |
| Roe | (2.6) | 0.0369 | (6.26) | 1.95 | 1.05 | 1.11 | |
| Ev To Operating Cash Flow | (5.9) | (2.08) | 1.08 | (1.87) | (5.49) | (5.76) | |
| Pe Ratio | (3.84) | 49.22 | (0.69) | (0.22) | (1.33) | (1.4) | |
| Return On Tangible Assets | (1.52) | 0.0704 | (0.8) | (0.97) | (0.71) | (0.75) | |
| Ev To Free Cash Flow | (5.9) | (2.08) | 1.08 | (1.87) | (5.49) | (5.76) | |
| Earnings Yield | (0.26) | 0.0203 | (1.46) | (4.59) | (0.75) | (0.79) | |
| Intangibles To Total Assets | 0.35 | 0.39 | 0.52 | 0.19 | 0.26 | 0.48 | |
| Net Debt To E B I T D A | 0.28 | (13.09) | 1.18 | (1.52) | (1.89) | (1.8) | |
| Current Ratio | 7.11 | 8.68 | 22.07 | 29.15 | 12.57 | 9.75 | |
| Tangible Book Value Per Share | (0.47) | 4.43 | (1.3) | (6.54) | (6.66) | (6.33) | |
| Graham Number | 43.56 | 9.4 | 17.72 | 24.82 | 21.3 | 20.24 | |
| Shareholders Equity Per Share | 5.7 | 10.32 | 1.49 | (3.75) | (4.37) | (4.16) | |
| Graham Net Net | (0.79) | 4.0 | (1.57) | (7.15) | (6.82) | (6.47) | |
| Interest Debt Per Share | 0.97 | 0.0228 | 1.18 | 15.19 | 13.88 | 14.57 | |
| Enterprise Value Over E B I T D A | (3.45) | 36.44 | 0.51 | (1.87) | (3.74) | (3.93) | |
| Price Earnings Ratio | (3.84) | 49.22 | (0.69) | (0.22) | (1.33) | (1.4) | |
| Price Book Value Ratio | 9.99 | 1.81 | 4.29 | (0.42) | (1.41) | (1.34) | |
| Price Earnings To Growth Ratio | (0.0894) | (0.48) | 2.68E-4 | 0.009934 | 0.0362 | 0.0409 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.